FDA recall D-0650-2017

Lupin Pharmaceuticals Inc. · Class III · drug

Product

Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09

Reason for recall

Failed Impurities/Degradation Specifications; Impurity A

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2015-12-07
Report date
2017-04-12
Termination date
2017-04-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0650-2017